Welcia Holdings Co., Ltd. (TYO: 3141)
Japan
· Delayed Price · Currency is JPY
2,221.00
+12.00 (0.54%)
Jan 20, 2025, 3:30 PM JST
Welcia Holdings Revenue
Welcia Holdings had revenue of 321.33B JPY in the quarter ending November 30, 2024, with 7.31% growth. This brings the company's revenue in the last twelve months to 1.26T, up 4.14% year-over-year. In the fiscal year ending February 29, 2024, Welcia Holdings had annual revenue of 1.22T with 6.38% growth.
Revenue (ttm)
1,258.80B
Revenue Growth
+4.14%
P/S Ratio
0.36
Revenue / Employee
82.35M
Employees
15,286
Market Cap
460.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 29, 2024 | 1,217.34B | 73.06B | 6.38% |
Feb 28, 2023 | 1,144.28B | 118.33B | 11.53% |
Feb 28, 2022 | 1,025.95B | 76.30B | 8.03% |
Feb 28, 2021 | 949.65B | 81.37B | 9.37% |
Feb 29, 2020 | 868.28B | 89.13B | 11.44% |
Feb 28, 2019 | Pro | Pro | Pro |
Feb 28, 2018 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Feb 28, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |